Oxidative Stress and Antioxidant Activity in Orbital Fibroadipose Tissue in Graves' Ophthalmopathy

REFERENCES

• Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: Reality and perspectives. Endocr Rev 2000; 21: 168–199
   PubMed Web of Science ®Google Scholar
• Burch H B, Wartofsky L. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 1993; 14: 747–793
   PubMed Web of Science ®Google Scholar
• Heufelder A E, Wenzel B E, Bahn R S. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts. J Clin Endocrinol Metab 1992; 74: 737–742
   PubMed Web of Science ®Google Scholar
• Korducki J M, Loftus S J, Bahn R S. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts. Invest Ophthalmol Vis Sci. 1992; 33: 2037–2042
   PubMed Web of Science ®Google Scholar
• Chang C C, Chang T C, Kao S C, Kuo Y F, Chien L F. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema. Acta Endocrinol (Copenh) 1993; 129: 322–327
   PubMedGoogle Scholar
• Burch H B, Lahiri S, Bahn R S, Barnes S. Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy. Exp Eye Res 1997; 65: 311–316
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Yang D, Miyake I, Koga M, Kameo J, Sato M, Inoue Y, Nonaka K. Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 1998; 83: 121–124
   PubMed Web of Science ®Google Scholar
• Balazs C, Kiss H, Farid N R. Inhibitory effect of pentoxifylline on HLA-DR expression and glycosaminoglycan synthesis by retrobulbar fibroblasts. Horm Metab Res 1998; 30: 496–499
   PubMed Web of Science ®Google Scholar
• Smith T J, Bahn R S, Gorman C A, Cheavens M. Stimulation of glycosaminoglycan accumulation by interferon γ in cultured human retroocular fibroblasts. J Clin Endocrinol Metab. 1999; 72: 1169–1171
   Web of Science ®Google Scholar
• Lu R, Wang P, Wartofsky L, Sutton B D, Zweier J L, Bahn R S, Garrity J, Burman K D. Oxygen free radicals in interleukin-1β-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients. Thyroid 1999; 9: 297–303
   PubMed Web of Science ®Google Scholar
• Bhat V B, Madyastha K M. Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. Biochem Biophys Res Commun 2001; 288: 1212–1217
   PubMed Web of Science ®Google Scholar
• Bartalena L, Tanda M L, Piantanida E, Lai A. Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications. Biofactors. 2003; 19: 155–163
   PubMed Web of Science ®Google Scholar
• Marcocci C, Bartalena L, Tanda M L, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei M P, Lepri P, Cartei F, Nardi M, Pinchera A. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 2001; 86: 3562–3567
   PubMed Web of Science ®Google Scholar
• Bartalena L, Marcocci C, Pinchera A. Treating severe Graves' ophthalmopathy. Bailliere's Clin Endocrinol Metab 1997; 11: 521–536
   PubMed Web of Science ®Google Scholar
• Bartalena L, Marcocci C, Pinchera A. Management of thyroid eye disease. Eur J Nucl Med. 2002; 29: S458–S465
   Google Scholar
• Bouzas E A, Karadimas P, Mastorakos G, Koutras D A. Antioxidant agents in the treatment of Graves' ophthalmopathy. Am J Ophthalmol 2000; 129: 618–622
   PubMed Web of Science ®Google Scholar
• Balazs C, Kiss E, Vamos A, Molnar I, Farid N R. Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO): A pilot study. J Clin Endocrinol Metab 1997; 82: 1999–2002
   PubMed Web of Science ®Google Scholar
• Prummel M F, Bakker A, Wiersinga W M, Baldeschi L, Mourits M P, Kendall-Taylor P, Perros P, Neoh C, Dickinson A J, Lazarus J H, Lane C M, Heufelder A E, Kahaly G J, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini M S, Rocchi R, Nardi M, Krassas G E, Halkias A. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: The first European Group on Graves' orbitopathy experience. Eur J Endocrinol 2003; 148: 491–495
   PubMed Web of Science ®Google Scholar
• Werner S C. Classification of the eye changes of Graves' disease. J Clin Endocrinol Metab 1969; 29: 982–984
   PubMed Web of Science ®Google Scholar
• Mourits M P, Prummel M F, Wiersinga W M, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol. 1997; 47: 9–14
   PubMed Web of Science ®Google Scholar
• Nunery W R, Martin R T, Heinz G W, et al. The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease. Ophthal Plast Reconstr Surg. 1993; 9: 7714
   Web of Science ®Google Scholar
• Mihaljevic B, Katusin-Razem B, Razem D. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med. 1996; 21: 53–63
   PubMed Web of Science ®Google Scholar
• Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502–522
   PubMed Web of Science ®Google Scholar
• Griffith O W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106: 207–212
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley L W, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988; 34: 497–500
   PubMed Web of Science ®Google Scholar
• Carlberg I, Mannervik B. Purification and characterization of glutathione reductase from calf liver. An improved procedure for affinity chromatography on 2′,5′-ADP-Sepharose 4B. Anal Biochem 1981; 116: 531–536
   PubMed Web of Science ®Google Scholar
• Paglia D E, Valentine W N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–169
   PubMed Web of Science ®Google Scholar
• Mishra O P, Delivoria-Papadopoulos M, Wagerle L C. Anti-oxidant enzymes in the brain of newborn piglets during ischemia followed by reperfusion. Neuroscience. 1990; 35: 211–215
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Sato M, Yamada K, Nonaka K. Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells. Clin Endocrinol (Oxf) 1992; 36: 91–95
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Sato M, Tanaka K, Ishisaka N, Kamachi J, Nonaka K. Inhibitory effects of nicotinamide on intercellular adhesion molecule 1 expression on cultured human thyroid cells. Immunology. 1993; 80: 330–332
   PubMed Web of Science ®Google Scholar
• Nagata S, Golstein P. The Fas death factor. Science. 1995; 267: 1449–1456
   PubMed Web of Science ®Google Scholar
• Hegedius L, Brix T H, Vestergaard P. Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest 2004; 27: 265–271
   PubMed Web of Science ®Google Scholar
• Metcalfe R A, Weetman A P. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: Possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf) 1994; 40: 67–72
   PubMed Web of Science ®Google Scholar
• Cheng A C, Pang C P, Leung A T, Chua J K, Fan D S, Lam D S. The association between cigarette smoking and ocular diseases. Hong Kong Med J 2000; 6: 195–202
   PubMedGoogle Scholar
• Palmer T. Understanding Enzymes. Ellis Horwood Limited, New York 1991
   Google Scholar
• Kumar S, Bahn R S. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 2003; 88: 4246–4250
   PubMed Web of Science ®Google Scholar
• Konuk O, Hondur A, Akyurek N, Unal M. Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy. Ocular Immunol Inflamm. 2007; 15: 1–7
   Web of Science ®Google Scholar